ETON Earnings
Latest Revenue37.6M
Latest Net Income11.6M
| Period | EPS | Revenue | Net Income | Rev YoY | EPS YoY |
|---|
| Q2 2026 | $0.42 | 37.6M | 11.6M | +98.6% | +520.0% |
| Q1 2026 | $0.06 | 24.3M | 1.6M | +40.4% | +200.0% |
| Q4 2025 | $0.06 | 21.3M | 1.5M | +82.7% | +400.0% |
| Q3 2025 | -$0.07 | 22.5M | -1927000 | +117.5% | -450.0% |
| Q2 2025 | -$0.10 | 18.9M | -2585000 | +108.6% | +16.7% |
| Q1 2025 | -$0.06 | 17.3M | -1572000 | +116.9% | -100.0% |
| Q4 2024 | -$0.02 | 11.6M | -598000 | +59.3% | +77.8% |
| Q3 2024 | $0.02 | 10.3M | 627.0K | +46.9% | +200.0% |
| Q2 2024 | -$0.12 | 9.1M | -3041000 | — | — |
| Q1 2024 | -$0.03 | 8.0M | -811000 | — | — |
| Q4 2023 | -$0.09 | 7.3M | -2256000 | — | — |
| Q3 2023 | -$0.02 | 7.0M | -579000 | — | — |
Eton Pharmaceutcials (ETON) — Earnings